Evidence map›Paper›PMID 20231687›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2010

Peripheral B cell tolerance and function in transgenic mice expressing an IgD superantigen.

Bao Hoa Duong, Takayuki Ota, Djemel Aït-Azzouzene, Miyo Aoki-Ota, José Luis Vela, Christoph Huber, Kevin Walsh, Amanda L Gavin, David Nemazee

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Harnessing Newton's third-law paradigm to treat autoimmune diseases and chronic inflammations.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2020
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The function and regulation of immunoglobulin D.Current opinion in immunology · 2011
    Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Bao Hoa DuongDepartment of Immunology and Microbial Science, Kellogg School of Science and Technology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Takayuki Ota
Djemel Aït-Azzouzene
Miyo Aoki-Ota
José Luis Vela
Christoph Huber
Kevin Walsh
Amanda L Gavin
David Nemazee
Scripps Research Institute · US

Funding

Novel Chemical and Immunological Approaches to Influenza TherapyU01AI074564 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI OLDSTONE, MICHAEL B · 2007 to 2011
$8.1M
Immune Tolerance in Non-Clonal Immune SystemsR01AI059714 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI NEMAZEE, DAVID · 2004 to 2013
$3.9M
INTERDISCIPLINARY TRAINING PROGRAM IN IMMUNOLOGYT32AI007606 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI NEMAZEE, DAVID · 1999 to 2013
$2.1M
NIAID NIH HHS AI74564NIAID NIH HHS R01 AI059714NIAID NIH HHS R01AI059714NIAID NIH HHS T32 AI007606NIAID NIH HHS T32AI007606NIAID NIH HHS U01 AI074564
6 · The paper itself

Abstract

Transitional B cells turn over rapidly in vivo and are sensitive to apoptosis upon BCR ligation in vitro. However, little direct evidence addresses their tolerance sensitivity in vivo. A key marker used to distinguish these cells is IgD, which, through alternative RNA splicing of H chain transcripts, begins to be coexpressed with IgM at this stage. IgD is also expressed at high levels on naive follicular (B-2) and at lower levels on marginal zone and B-1 B cells. In this study, mice were generated to ubiquitously express a membrane-bound IgD-superantigen. These mice supported virtually no B-2 development, a greatly reduced marginal zone B cell population, but a relatively normal B-1 compartment. B cell development in the spleen abruptly halted at the transitional B cell population 1 to 2 stage, a block that could not be rescued by either Bcl-2 or BAFF overexpression. The developmentally arrested B cells appeared less mature and turned over more rapidly than nontransgenic T2 cells, exhibiting neither conventional features of anergy nor appreciable receptor editing. Paradoxically, type-2 T-independent responses were more robust in the transgenic mice, although T-dependent responses were reduced and had skewed IgL and IgH isotype usages. Nevertheless, an augmented memory response to secondary challenge was evident. The transgenic mice also had increased serum IgM, but diminished IgG, levels mirrored by the increased numbers of IgM(+) plasma cells. This model should facilitate studies of peripheral B cell tolerance, with the advantages of allowing analysis of polyclonal populations, and of B cells naturally lacking IgD.

Indexed as

AnimalsAutoantigensB-Lymphocyte SubsetsBone Marrow TransplantationCell DifferentiationCell LineageHumansImmune ToleranceImmunoglobulin Constant RegionsImmunoglobulin DLymphoid TissueMiceMice, Inbred C57BLMice, TransgenicPrecursor Cells, B-LymphoidSingle-Chain AntibodiesAutoantigensImmunoglobulin Constant RegionsImmunoglobulin DSingle-Chain AntibodiesSuperantigens

Identifiers

PMID20231687
PMCPMC2874719
OpenAlexW2108882136

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.